Skip to main content

Uncategorised

Day 4 - Thursday Sept 26


Day 4: Base Hospital Updates and Strategies Session

Thursday Morning Breakfast

Thursday, September 26, 2024, at Andaz, 7:00-9:00am

Start your Thursday morning with a hearty breakfast offered to guests who have remained at OBHG24. Enjoy a variety of gourmet options while reconnecting with colleagues and reflecting on the enriching experiences of the conference. This relaxed morning meal sets a positive tone for the final ½ day business meeting of OBHG staff, providing an excellent opportunity to engage in casual conversations and prepare for the sessions ahead.

OBHG24 Momentum Meeting

Base Hospital Updates and Strategies Session

Thursday, September 26, 2024, at Andaz, 9:00am - 11:00am

OBHG24 invites base hospital staff to an engaging wrap-up morning session dedicated to sharing updates, news, ideas, and strategies from each base hospital. This session is an excellent opportunity for attendees to pick a few of your favourite achievements, projects, or trends and share them with the rest of us. Each base hospital is encouraged to come prepared to talk for 20 minutes, highlighting both challenges and accomplishments in areas such as medical direction, quality, education, technology, IT, patient-centred care initiatives, or other significant work that is underway, completed, or anticipated.
This collaborative session aims to foster an environment of knowledge-sharing and inspiration. It’s your chance to showcase the innovative work happening at your base hospital and learn from the experiences of others. By discussing our successes and obstacles, we can collectively enhance our practices and drive forward the field of paramedicine.
Prepare to share your insights, celebrate your achievements, and explore new ideas that can benefit our entire community. We look forward to hearing from you and sending you off with the momentum of OBHG24.

9:00am - 11:00am @ Andaz - Dalhousie room

OBHG/MAC/Working Groups - Updates

  • Medical Advisory Committee (MAC)
  • Education Subcommittee (ESC)
  • Data Quality Management (DQM)
  • OSCE Scenarios working group

    Online Medical Consultation Project

    10:00 am - OAPC/OBHG Working Group Update

    RPPEO

    • Low Acuity Alternate Pathways
    • CAPSA patient experience work
    • Methoxyflorane studies
    • DEM/PTM fellowship, Bootcamp

    Final Remarks/Passing the torch to next OBHG AGM host

    11:00am - Safe travels back home

    Lunch Go Lunches @ Andaz - Dalhousie Lounge

    Read more …Day 4 - Thursday Sept 26

    • Hits: 567

    De-certification

    De-activation and De-certification

    Both de-activation and de-certification signify a stop in a paramedic's authorization from the Medical Director to perform controlled medical acts. Whether de-activated or de-certified, the paramedic is no longer eligible to work as a paramedic within the certifying base hospital, except in the case of a partial clinical de-activation (see below). De-activation and de-certification may be the result of several different processes outlined below.

    Administrative De-activation

    Most administrative de-activations are due to a paramedic's absence from work for periods greater then 90 days. After ninety days away from practice, paramedics are required to undertake a Return to Clinical Practice process and are deactivated until that process is complete. Following completion of a Return to Clinical Practice process, the RPPEO reactivates paramedics' certification.

    Other potential reasons for administrative de-activation include failure to complete annual maintenance of certification activities by the deadline or failing to respond to RPPEO requests for information during audits. It's also used when the RPPEO anticipates that a paramedic plans to continue practising within the RPPEO region, but is missing some aspect of their administrative file in order to continue. In these rare cases of missing information, administrative de-activation can almost always be reversed by providing the missing administrative details.

    Clinical De-activation

    When the Medical Director has serious concerns about the safety and quality of clinical care, they may use clinical de-activiation to limit a paramedic's activity. In the case of a full clinical de-activation, the Medical Director removes a paramedic from all clinical activities, while a partial de-activation means removing authorization for certain specified clinical activities. Following investigation of the issues, paramedics may be required to undergo remediation or other educational activities to have their certification re-reactivated. While the RPPEO maintains this process should it be required, de-activation for concerns about patient care or safety is exceedingly rare.

    De-certification

    The RPPEO de-certifies paramedics who have left our region or who are retired from practice. There is a Ministry of Health mechanism for de-certification on the basis of patient safety concerns described in Appendix 6 of the Advanced Life Support Patient Care Standards, however, clinical decertification is extremely rare. When it does occur, it's at the recommendations of a Paramedic Practice Review Committee (PPRC). By the PPRC's review and recommendation, a paramedic who no longer meets the requirements set out in the provincial Patient Care Standards, the RPPEO's policies and/or other requirements of the Ministry of Health will be de-certified. The authorization to practice as a paramedic under the jurisdiction of the base hospital and the authorization to perform delegated controlled medical acts are thereby withdrawn.

    For more details about de-activation and de-certification, see the RPPEO Certification Policy.

    Did You Miss the Maintenance of Certification Deadline?

    No one wants an administrative deactivation, but that's what the automation bot working inside MedicNET does on February 1 if you're missing requirements.

    If you're in the group with administrative deactivation, check your MedicNET profile to see what you're missing. Read the FAQ below to find out how to proceed when you're ready for your paramedic certification to be re-activated.

    The humans at the RPPEO are always happy to hear from you! For more about your annual CME requirements or other recertification issues, contact us at certification@rppeo.ca or 877-587-7736.

    For those who have successfully re-certified for the current year, congratulations and thank you!

    Frequently Asked Questions

    • Q. When is the deadline?

      A. January 31, each year at 23:59:59.

    • Q: What are the requirements for Annual Maintenance of Certification?

      A: The requirements are detailed by scope of practice in the RPPEO’s Certification Policy CERT 100 available here.

    • Q. How do I find out what I am missing in the requirements?

      A: Please log into our website and view your profile in MedicNET (see instructions)

    • Q. If I cannot obtain ten patient contacts before the deadline, what do I do?

      A. An online course is available in MedicLEARN as an approved alternative.

      Title of the course: 202x-202x MOC 10 Patient Contacts Equivalency.

      Direct link to MedicLEARN:

    • Q. Who do I contact RPPEO if I have a question about my requirements?

      A. You can email us at certification@rppeo.ca or call MedicLINE at 1-877-587-7736 Option 1.

    • Q. What will happen to my certification status with RPPEO if I miss the deadline?

      A. The system will issue you an administrative deactivation letter.

    • Q. If I get deactivated, how do I get reactivated?

      A. Simply complete the missing requirement(s) online as soon as possible. Once all requirements are met, RPPEO will reactivate you.

    How to review your MedicNET profile

    • Login to RPPEO

      Go to MedicNET

    • Click My Profile

    • Select MoC tab

      Just below your name

    • Select the year

      From the Certification period dropdpwn select the desired year to review.

    Read more …De-certification

    • Hits: 7076

    Elective CME Pre-Approval Request

    Elective CME Pre-Approval Form

    Submit a RequestEnsure to enter your EHS# at the bottom of the form.
    You may attach a file below to help support your request.

    Please enter paramedic's name.
    Please enter a valid date.
    Invalid Input
    Invalid Input
    Invalid Input
    Please provide the detail of your request.
    Please provide the detail of your request.
    Please provide the detail of your request.
    Invalid Input
    Invalid Input
    Invalid Input
    EHSN is a five digits number.
    Please enter your full name.
    Please enter a valid email address.

    Read more …Elective CME Pre-Approval Request

    • Hits: 1628

    Entry to Practice - Thank You

    Completed!education fp

    Thank you for completing this Online Learning Module using the RPPEO's E-Learning Portal. If you have any questions, comments or concerns please direct them to certification@rppeo.ca

    We hope you have enjoyed this part of the process and welcome any feedback on what we can improve upon.

    RPPEO Certification Team

    • Hits: 2456

    Frequently Asked Questions

    Frequently Asked Questions

    • Patellar Dislocation (Updated Nov 12)

      Q - Why are we only allowed to reduce lateral patella dislocations and not medial dislocations?

      A - Patellar dislocations tend to occur in a lateral direction (85% of the time), partly because the direction of pull of the quadriceps muscle is slightly lateral to the mechanical axis of the limb. Medial instability is rare and more likely to result from congenital conditions, quadriceps atrophy, or iatrogenically. The condyles of the patella are larger medially so in most cases the 10% of medial dislocations occur 2nd to trauma and therefore would be contraindicated for relocation. Lateral happens spontaneously. If someone spontaneously dislocated medially, they could call BHP and we could provide a verbal order if no other risk to relocate; the process is similar.

      Q - Can I still perform this maneuver if there are other possible ligamentous injuries?

      A - It will be often difficult to ascertain if ligamentous injuries are also present in these patients. You are still able to reduce the patella even if there are concerns for ligamentous injury.

      Q - Why is it recommended that the patient be transported after patella reduction?

      A - Most of these patients will require imaging, immobilization with a cast or splint, and an orthopedic referral. Many will end up in a cast for weeks.

      Q - What are the potential complications of patellar dislocation?

      A - Complications can include ligament or cartilage damage, fractures, nerve compression, and vascular compromise.

      Q - Do you recommend that we provide analgesia beforehand?

      A - Pain relief may best come from the reduction of the patella vs simply giving the patient analgesia. If the patient can tolerate it, then reduction may be best as the first course of treatment. However, if your patient is unable to tolerate it, we recommend providing some analgesia prior to the reduction.

      Q - Why is there an upper age range for this medical directive?

      A - Aging is a major risk factor for fractures, and we do not want to reduce a knee that may have a coexisting fracture. If you believe there is minimal-to-no risk for a lateral patellar reduction to a patient over 50 years of age, a consult patch to a BHP would be necessary for further guidance, discussion, and medical direction.

      Q - What is the reason for the lateral patellar reduction being restricted to >= 10 years of age?

      A - The patella in children under 10 isn’t usually fully ossified, and statistically, a patellar dislocation is rare below that age.

      Q - What about patients with known ACL/MCL tears or knee replacements. Is it safe to reduce lateral patellae in this patient population?

      A - There is no difference in diagnosis or technique because the patella is anterior to the knee joint therefore these other knee issues should not interfere with the lateral patella reduction procedure.

      Q - After the patellar reduction I anticipate that this patient population may request a refusal of transport. Is this recommended? If not, what will the follow-up in hospital entail?

      A - Most physicians will do an X-Ray to rule out fractures. Furthermore, there is a significant amount of discussion surrounding aftercare of this type of injury such as knee immobilization, no bending, rest, ice, anti-inflammatory medications. The knee is still considered unstable even if the reduction was successful, so the immobilization helps it scar down and be more stable. Along with these education pieces there is often a referral to ortho and physio for additional follow-ups. The future state might be that this patient population could follow-up by private vehicle to a clinic/ED for care. Being seen by a physician is important for further investigation, ongoing referral pathway activation and long-term management planning.

    • Ketamine for Analgesia (Updated Nov 7)

      Q - Can I begin administering ketamine for pain after I complete my CME?

      A - Although ACP’s currently carry Ketamine and they will be trained this fall on how to administer it for analgesia, the ALS PCS Medical Directive will not be available until Feb. 1, 2025, and thus paramedics must wait until then to utilize this directive.

      Q - For the hypotensive patient needing pain control, where do we start?

      A - Clinical considerations, addressing hemodynamics is one way, and you may also consider patient preference. Opiate analgesics are still first line, fentanyl now has no BP criteria, as does ketorolac. Go low and slow with your opioids. If the patient is really unstable, and you don’t think the patient can tolerate opiates, you can go to ketamine.

      Q - Should we consider lowering the ketamine dose in a catecholamine depleted patient?  We know that RSI doses are usually reduced by half, but not sure if this applies for ketamine for analgesia?

      A - If paramedics have a suspicion of catecholamine depletion (fatigue, cognitive impairment, hypotension, poor circulation, chronic pain, etc), then they should use another analgesia choice, as they now have lots to choose from: morphine and fentanyl, in addition to the other non-opioid medications.  We should avoid Ketamine if the assessment and history suggest concerns for catecholamine depletion.

    • Tachydysrhythmia Management (Updated Oct 4)

      Q - Should I start an IV line prior to attempting the VM on a patient?

      A - It is not necessary to start an IV line in these patients as the procedure is very safe and has very little chance of making them completely unstable requiring an IV line. After thorough Hx gathering and assessment you will have deemed your patient hemodynamically stable to attempt the VM to convert them out of their SVT.

      Q - How common are adverse events when carrying out the VM or mVM?

      A - Adverse events are rare but can occur. The most common documented in the literature is hypotension. No serious adverse events have ever been documented. All other adverse events documented were clinical manifestations such as dizziness, light-headedness, weakness, chest pain and hypotension, all of which can be managed by primary care paramedics on the rare occasion they occur.

      Q - Should I be giving ASA to my chest pain patient if I believe Tachycardia is the source of the ischemia?

      A - Rate related cardiac ischemia patients should receive ASA when possible. Ischemia signs may include respiratory distress or left arm, jaw or chest pain. These patients then should be considered for transport to hospital to have further cardiac workup.

      Q - What happens if my patient converts out of the SVT with the second VM or mVM but while preparing for transport or treat and discharge they go back into an SVT?

      A - This is a rare clinical event. However, exercise your clinical judgement and remain patient centered. It is obvious that the VM/mVM previously performed precipitated conversion therefore we know it’s working. You can go ahead and coach the patient through another VM/mVM. As alsways, if you would like further guidance, a consult patch to the BHPs is always available to you.

    • Gastric Port Suctioning (Updated Oct 23)

      Q - Do we leave the suction tubing in, or insert/remove PRN?

      A - Once the suction catheter is successfully inserted into the Suction Port of the iGel, the next step is to tape it down so it does not displace.  It is recommended to leave the suction catheter in place for the duration of the call.

      Q - Do we leave the tubing attached to suction, or attach/remove PRN?

      A - It would be adventageous to leave the suction tubing attached to the suction, in case more suctioning is required, and the suction can simply be turned back on.

      Q - How long are we permitted to suction, via the gastric port?

      A - According to the Medical Directive, unlike ETT or Tracheostomy suctioning, which is limited to 10 seconds, there is no limit to how long you may suction via the gastric port of an SGA.  The directive states until fluid stops, or there is no fluid return for 15 seconds.

    • Traumatic Hemorrhage (Updated Dec 4)

      Q - I already carry TXA as part of my role with OPS.  Can I start administering it after I complete CME?

      A - Although special operations paramedics in Ottawa currently carry TXA, and will be trained following CME, they are NOT permitted to administer this for 911 calls (even with a patch) until the Medical Directive comes out Feb. 1, 2025, in the new ALS PCS.

      Q - Are there any patient presentations not covered by the Medical Directive, where I could consider TXA, perhaps with a patch?

      A - TXA should not be given to pt’s with isolated extremity fractures or even amputations where the hemorrhage can be controlled with a tourniquet/direct pressure. It should also not be given to pt’s with rectal bleeds, epistaxis, severe menstrual periods, or post-partum hemorrhage as it is currently only for trauma pt’s in the prehospital setting (for now).

      Q - What role does a fluid challenge play in trauma management?

      A - Fluid in trauma patients/permissive hypotension: Remember, fluid has its pitfalls in trauma patients when looking at the trauma triad (diluting the blood, worsening hypothermia/coagulation, etc.) however, if a trauma pt. has a systolic BP of 70 (for example) then they are not perfusing and require fluid as per the ALS PCS. This does not mean we have to get their BP to 120 systolic. We can provide enough fluid for the pt’s BP to get to 90 systolic and stop/monitor – enough for them to perfuse while minimizing the risks of fluid in trauma.

      Q - Can I give TXA in a single IM injection?

      A - When administering TXA IM it is important to remember the max volume. Since the entire vial is administered you must push 5ml in each vastus lateralus.

      Q - Can we administer TXA IM in the vastus lateralis when applying a pelvic binder?

      A - Yes, you really have no other choice due to the volume of fluid being administered IM. IV is the preferred route due to its immediate onset and studies show this to be the most effective route.

      Q - Why are we only administering 1g of TXA versus 2g?

      A - Studies show that an initial dose of 1g followed by a second dose of 1g over 8 hours by the hospital is most beneficial. Although 2g upfront may be easier to administer, the studies show no real benefit to this (CRASH II Study). The volume would also be too large a dose for IM and would be limited to IV only.

      Q - If the preferred route for TXA is IV, do I need to obtain IV access prior to leaving scene with my trauma patient?

      A - The preferred route of TXA is IV however, this is not meant to delay transport. There is no real rush in administering TXA IM especially with competing priorities in massive trauma pt’s. It is better to complete CABCDE, rapid transport, and obtain IV access/administer TXA later when en route. Stopping the bleed and getting these pt’s to a trauma centre trumps TXA administration (don’t rush!). Although this medication has its benefits, it is not what is going to save your trauma pt’s life!

      Q - Why is the preliminary Medical Directive suggesting a 10 minute administration time?

      A - The reason for the 10 minutes for TXA administration is to not cause profound hypotension by pushing it too quickly. We are trying to have this changed in the MD as the drug monograph states over 5 mins. As long as it is pushed slowly, it should not cause hypotension. TXA can be mixed into mini bags of 50cc NaCl or D5W but should not be mixed in anything larger as it does not require dilution, and the pt. must receive the full vial.

      Q - The conditions for administration of TXA call for a HR and a BP.  What about in a traumatic arrest, MOI indicates significant Internal Hemorrhage, would TXA be beneficial?  We appreciate it's not in our protocol, just curious.

      A - Focus in traumatic arrest should be on reversible causes or they won’t survive. Focus on patency of airway, oxygenation, decompression of a tension pneumothorax, and control of serious hemorrhage (tourniquet, hemostatic dressings). TXA would be of no benefit if these interventions don’t establish ROSC.

      Q - If I'm transporting a traumatic VSA, Can I give TXA?

      A - TXA in this case is exceedingly unlikely to be helpful.  Since there is no likelihood of benefit, it’s really not indicated in the medical directive, and not recommended in any guidelines, a patch would be required if the patient has no vital signs. Since there is no evidence for benefit and it’s not indicated, we’re not recommending TXA for trauma cardiac arrest at this time. The focus should remain on treating reversible causes (bleeding, airway management and decompressing tension pneumo).

    • Substance Use Healthcare (Updated Oct 24)

      Q - Why is RPPEO including a Regional Patch Point for administration of buprenorphine/naloxone?

      A - This is a mandatory patch point for RPPEO currently despite not being written in the ALS PCS. Reasoning: this is new for physicians and paramedics, and many of these individuals choose not to be transported to the hospital thus, each service is looking at unique alternate patient care models within their community. We want to provide quality and safe patient care.

      Q - Can we still administer suboxone if the patient states they do not want to go to the hospital?

      A - Yes, this is also why we have a mandatory patch point for now as providing treatment is patient centered and thus a follow up plan is important.

      Q - Why does the Medical Directive not call the new medication Suboxone?

      A - Brand names such as Suboxone are not permitted in ALS PCS hence why it is written buprenorphine/naloxone. To clarify, this IS Suboxone. It is a combination of these two medications in a tablet format. When taken correctly, the naloxone component has NO effect. The naloxone is strictly mixed in as a deterrent to crushing of the pills and injecting it, as the naloxone WILL have an effect if taken this way. 

      Q - I hear that alternate pathways will be part of the treatment with buprenorphine/naloxone, instead of always transporting to hospital?

      A - Work with your service to determine referral pathways and alternate dispositions to be able to discuss with the BHP when patching. Each service will be unique in how they roll out Suboxone and who they roll it out to. For example, some are starting with just their CP’s for a couple of reasons: They have access to different pathways for these patients and because it is a controlled substance, it will be a lot for the entire service to roll that out all at once (i.e. narcotic boxes).

      Q - Can we ask for a third dose of buprenorphine/naloxone?

      A - 24mg is a big dose. Most, if not all receptors would be occupied at this point. The added benefit for another 8mg would typically be pretty low, and there’s very little if any evidence for doses bigger than 24mg. That being said, you can always patch. Never say never. If somebody had a COWS that went from 20 to 10 with 24mg, the patient said they were feeling a lot better but still uncomfortable and needed more, the docs may consider it (rare though). Usually if they aren’t getting better with 24mg it’s because we’ve precipitated withdrawal or there’s other things at play - other substances, other withdrawal, etc.

      Q - Why do we recommend opioids to people with OUD, but not alcohol or Valium as long-term treatment for alcohol use disorder?

      A - The two main differences are the rapid loss of tolerance and the dangerous street supply. Neither of those are factors in alcohol use disorder, and both are key reasons for the opioid kill rate.

      Q - How long can someone take Suboxone?

      A - Some individuals choose to be on it for years to attain stability. Coming off suboxone is never the goal early on, and there is never a push to get people off it.

      Q - How long does it take to be abstinent from opioid use for someone to become opiate naive again?

      A - Tolerance can be lost very quickly. Within days. Which is another reason why the current problem is so deadly. Someone tries to stop and then uses again, or goes to jail for a few days, then goes back to their original use and dies because they’ve lost tolerance.

      Q - Why does someone need to have a history of drug use to receive Suboxone?

      A - A one- time user shouldn’t have dependence. It usually takes at least several days but more likely weeks of regular use to develop dependence. That said, if their COWS score is 30 after naloxone that is good evidence they are dependent. Two great questions to ask your patient are 1.) Do you use opioids every day? 2.) Do you get sick when you stop? If the answer is yes to both, then there is a very high chance they are an opioid user. Thus, a one-time user who took a bad supply and overdosed, would not benefit from Suboxone as they likely would not be in severe withdrawals after naloxone administration. They require education and follow up care with their family physician if they are using recreationally to escape underlying mental health issues.

      Q - What are the docs looking for in a patch?

      A - Many patients with this condition will be dead within one year – not many other conditions have this kill rate and we are trying to move the needle. Opiate agonist therapy reduces mortality and improves the lives of these individuals. We are having a difficult time connecting them to appropriate pathways/referrals and paramedics will be that link (work in progress), and may be the last/only healthcare professional they interact with. There are many clinics and options out there however, we need to make that connection/plan. Start having these conversations now. They will also speak to you about harm reduction, never using alone, using naloxone, etc.

      Q - It seems like the dosing interval for suboxone is rather short and may not be long enough to see the effects of suboxone before we start our second dose. One paramedic on the mental health team (MWRT) mentioned in hospital the dosing interval is Q30 or Q1H.  Is there a concern for overdosing?

      A - It’s important to remember that the risk of overdose with Suboxone (buprenorphine/naloxone) is relatively low, especially in the doses we use in naloxone induced withdrawal and indications in prehospital settings. The buprenorphine component has a ceiling effect on respiratory depression, meaning it plateaus and significantly reduces the risk of overdose compared to other opioids.
      In the prehospital setting, a shorter interval such as q5 minutes between doses can be safe, especially in situations where the patient is not improving after the initial dose. However, if paramedics notice signs of improvement, it's perfectly reasonable to delay and assess before administering a second dose. This allows time for the medication to take effect, as buprenorphine can take up to 15 minutes or more to show its full benefits, however, there is some action within the first 5 min.
      In hospitals, dosing intervals like q30 minutes or q1 hour are often used but remember it typically is not naloxone precipitated withdrawal, but the prehospital environment is more dynamic, and the priority is for more rapid stabilization. We adapt these intervals to ensure patients receive timely care, with the flexibility to adjust based on the patient's response.

    Read more …Frequently Asked Questions

    • Hits: 3101

    Intravenous (IV) Access and Therapy by Primary Care Paramedics

    There are 2 types of authorization for PCPs IV cannulation and therapy.

    “PCP Assist IV” is authorization for a PCP to cannulate a peripheral IV at the request and under the direct supervision of an ACP. The patient must require a peripheral IV in accordance with the indications listed in the Intravenous and Fluid Therapy Medical Directive - Auxiliary. The ACP will perform all IV therapy in accordance with the Intravenous and Fluid Administration Medical Directive once intravenous access is obtained. PCPs authorized in PCP Assist IV are not authorized to administer IV therapy.

    “PCP Autonomous IV” is authorization for a PCP to independently cannulate an IV according to the Intravenous and Fluid Therapy Medical Directive – Auxiliary.  PCPs authorized in PCP Autonomous IV are authorized to administer IV therapy according to applicable Medical Directives.

    Authorization for each type shall meet the requirements established by the provincial Medical Advisory Committee.


    There are 2 types of authorization for PCPs IV cannulation and therapy.
    “PCP Assist IV” is authorization for a PCP to cannulate a peripheral IV at the request and under the direct supervision of an ACP. The patient must require a peripheral IV in accordance with the indications listed in the Intravenous and Fluid Therapy Medical Directive - Auxiliary. The ACP will perform all IV therapy in accordance with the Intravenous and Fluid Administration Medical Directive once intravenous access is obtained. PCPs authorized in PCP Assist IV are not authorized to administer IV therapy.
    “PCP Autonomous IV” is authorization for a PCP to independently cannulate an IV according to the Intravenous and Fluid Therapy Medical Directive – Auxiliary. PCPs authorized in PCP Autonomous IV are authorized to administer IV therapy according to applicable Medical Directives.
    Authorization for each type shall meet the requirements established by the provincial Medical Advisory Committee.

    PCP

    • Hits: 6338